Structure Database (LMSD)

Back

LMSD: Lipid classification search results

N-acyl amines [FA0802]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA08020234 N,N-bis(4-acetamidobutyl)-15-methylhexadec-6E-enamide N,N-bis(4-acetamidobutyl)-15-methylhexadec-6E-enamide C29H55N3O3 493.424342
LMFA08020235 (E)-15-methyl-N,N-bis(4-pentanamidobutyl)hexadec-6-enamide 15-methyl-N,N-bis(4-pentanamidobutyl)hexadec-6E-enamide C35H67N3O3 577.518242
LMFA08020238 N-(3-oxo-heptanoyl)-homoserine thiolactone N-(3-oxo-heptanoyl)-homoserine thiolactone C11H17NO3S 243.092916
LMFA08020239 N-(3-oxo-octanoyl)-homoserine thiolactone N-(3-oxo-octanoyl)-homoserine thiolactone C12H19NO3S 257.108566
LMFA08020240 N-(3-oxo-hexanoyl)-homoserine thiolactone N-(3-oxo-hexanoyl)-homoserine thiolactone C10H15NO3S 229.077266
LMFA08020241 N-(3-oxo-dodecanoyl)-homoserine thiolactone N-(3-oxo-dodecanoyl)-homoserine thiolactone C16H27NO3S 313.171166
LMFA08020243 alpha-N-(3-(11,12-methylene)-octadecanoyloxy-hexadecanoyl)-L-ornithine (2S)-5-amino-2-(3-(11,12-methylene-octadecanoyloxy)-hexadecanamido) pentanoic acid C40H76N2O5 664.575423
LMFA08020244 alpha-N-(3-(3-hydroxy-11,12-methylene-octadecanoyloxy)-hexadecanoyl)-L-ornithine (2S)-5-amino-2-(3-(3-hydroxy-11,12-methylene-octadecanoyloxy) hexadecanamido) pentanoic acid C40H76N2O6 680.570338
LMFA08020245 N-palmitoyl dopamine N-[2-(3,4-dihydroxyphenyl)ethyl]-9Z-hexadecenamide NA 24:5;O2 C24H39NO3 389.292994
LMFA08020246 N-stearoyl dopamine N-[2-(3,4-dihydroxyphenyl)ethyl]-octadecanamide NA 26:4;O2 C26H45NO3 419.339944
LMFA08020247 N-margaroyl taurine N-heptadecanoyl taurine NAT 17:0 C19H39NO4S 377.259981
LMFA08020248 N-nonadecanoyl taurine N-nonadecanoyl taurine NAT 19:0 C21H43NO4S 405.291281
LMFA08020249 N-arachidoyl taurine N-eicosanoyl taurine NAT 20:0 C22H45NO4S 419.306931
LMFA08020250 N-heneicosanoyl taurine N-heneicosanoyl taurine NAT 21:0 C23H47NO4S 433.322581
LMFA08020251 N-tricosanoyl taurine N-tricosanoyl taurine NAT 23:0 C25H51NO4S 461.353881
LMFA08020252 N-lignoceroyl taurine N-tetracosanoyl taurine NAT 24:0 C26H53NO4S 475.369531
LMFA08020253 N-pentacosanoyl taurine N-pentacosanoyl taurine NAT 25:0 C27H55NO4S 489.385181
LMFA08020254 N-hexacosanoyl taurine N-hexacosanoyl taurine NAT 26:0 C28H57NO4S 503.400831
LMFA08020255 N-(9Z-nonadecenoyl) taurine N-(9Z-nonadecenoyl) taurine NAT 19:1 C21H41NO4S 403.275631
LMFA08020256 N-gondoyl taurine N-(11Z-eicosenoyl) taurine NAT 20:1 C22H43NO4S 417.291281
LMFA08020257 N-nervonoyl taurine N-(15Z-tetracosenoyl) taurine NAT 24:1 C26H51NO4S 473.353881
LMFA08020258 N-erucoyl taurine N-(13Z-docosenoyl) taurine NAT 22:1 C24H47NO4S 445.322581
LMFA08020259 N-(14Z-tricosenoyl) taurine N-(14Z-tricosenoyl) taurine NAT 23:1 C25H49NO4S 459.338231
LMFA08020266 N6-lauroyl lysine N6-dodecanoyl lysine C18H36N2O3 328.272593
LMFA08020268 N6-goshuyoyl lysine N6-(5Z,8Z-tetradecadienoyl) lysine C20H36N2O3 352.272593
LMFA08020269 N6-myristoyl lysine N6-tetradecanoyl lysine C20H40N2O3 356.303893
LMFA08020270 N-linoleoyl dopamine N-(9Z,12Z-octadecadienoyl) dopamine NA 26:6;O2 C26H41NO3 415.308644
LMFA08020271 N-linolenoyl dopamine N-(9Z,12Z,15Z-octadecatrienoyl) dopamine NA 26:7;O2 C26H39NO3 413.292994
LMFA08020272 Dihomo-gamma-linolenoyl dopamine N-(8Z,11Z,14Z-eicosatrienoyl) dopamine NA 28:7;O2 C28H43NO3 441.324294
LMFA08020273 N-gamma-linolenoyl dopamine N-(6Z,9Z,12Z-octadecatrienoyl) dopamine NA 26:7;O2 C26H39NO3 413.292994
LMFA08020274 N-(7Z,10Z,13Z-16Z-docosatetraenoyl) dopamine N-(7Z,10Z,13Z-16Z-docosatetraenoyl) dopamine NA 30:8;O2 C30H45NO3 467.339944
LMFA08020275 alpha-N-(3-hexadecanoyloxy-hexadecanoyl)-L-ornithine (2S)-5-amino-2-(3-hexadecanoyloxy-hexadecanamido)pentanoic acid C37H72N2O5 624.544123
LMFA08020276 Semiplenamide B N-(2-methyl-2Z,6E-eicosadienoyl)-2-acetoxyethylamine NA 25:3;O2 C25H45NO3 407.339944
LMFA08020277 Semiplenamide C N-(2-methyl-2Z-hexadecenoyl)-1-hydroxypropyl-2(S)-amine NA 20:1;O C20H39NO2 325.298079
LMFA08020278 Semiplenamide D N-(2-methyl-2Z-eicosenoyl)-1S-methyl-2-acetoxyethylamine NA 26:2;O2 C26H49NO3 423.371244
LMFA08020279 Semiplenamide E N-(2-methyl-2Z-octadecenoyl)-1S-methyl-2-acetoxyethylamine NA 24:2;O2 C24H45NO3 395.339944
LMFA08020280 Semiplenamide G N-(2-methyl-2S,3R-epoxy-octadecanoyl)-1-methyl-2-acetoxyethylamine NA 24:2;O3 C24H45NO4 411.334859
LMFA08020281 Semiplenamide F N-(2-methyl-2S,3R-epoxy-octadecanoyl)-1-hydroxypropyl-2-amine NA 22:1;O2 C22H43NO3 369.324294
LMFA08020282 Granadaene (2S)-5-amino-2-(27R-O-alpha-L-rhamnopyranosyl-2E,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E,24E-octacosadodecaenoyl)pentanoic acid C39H52N2O8 676.372368
LMFA08020283 N-3-hydroxy-13-methyl-hexadecanoyl glycyl-L-serine C22H42N2O6 430.304288
LMFA08020284 Topostin B553 N-(3R-(13-methyl-tetradecanoyloxy)-hexadecanoyl)-glycine C33H63NO5 553.470624
LMFA08020285 Topostin D654 N-(15-methyl-3R-(13-methyl-tetradecanoyloxy)-hexadecanoyl)-glycylserine C37H70N2O7 654.518303
LMFA08020286 Topostin D654 N-(3R-(13-methyl-tetradecanoyloxy)-hexadecanoyl)-glycylserine C36H68N2O7 640.502653
LMFA08020287 N-(14-methyl-3S-(13-methyl-4Z-tetradecenoyloxy)-pentadecanoyl)-glycine NA 33:3;O4 C33H61NO5 551.454974
LMFA08020288 Bacillamidin A N-(9-methyldecanoyl)-dimethyaspartate NA 17:2;O4 C17H31NO5 329.220224
LMFA08020289 Bacillamidin B N-(10-methyldodecanoyl)-dimethyaspartate NA 19:2;O4 C19H35NO5 357.251524
LMFA08020290 Bacillamidin D N-[(3R)-1-(2-methylpropyl)-2,5-dioxopyrrolidin-3-yl]-9-methyldecanamide C19H34N2O3 338.256943
LMFA08020291 Bacillamidin C N-[(3R)-2,5-dioxopyrrolidin-3-yl]-10-methyldodecanamide C17H30N2O3 310.225643
LMFA08020292 Bacillamidin E N-[(2S,3S)-2-[(1S)-1-hydroxy-2-[[(1S)-1-[(3S)-8-hydroxy-1-oxo-3,4-dihydroisochromen-3-yl]-3-methylbutyl]amino]-2-oxoethyl]-5-oxooxolan-3-yl]-13-methyltetradecanamide C36H56N2O7 628.408753
LMFA08020297 Mutanamide N-(3-oxo-decanoyloxy)-L-leucyl-L-alanine C19H34N2O5 370.246773